# Concurrent Xeloda and Radiotherapy for Bone Metastases

> **NCT00192777** · PHASE2 · UNKNOWN · sponsor: **Rambam Health Care Campus** · enrollment: 20 (estimated)

## Conditions studied

- Solid Tumors
- Bone Metastases

## Interventions

- **DRUG:** Xeloda
- **PROCEDURE:** External Beam Radiotherapy

## Key facts

- **NCT ID:** NCT00192777
- **Lead sponsor:** Rambam Health Care Campus
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-11
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2007-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00192777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00192777, "Concurrent Xeloda and Radiotherapy for Bone Metastases". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT00192777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*